| dc.contributor.author | Norris, T. | |
| dc.date.accessioned | 2021-02-22T11:37:08Z | |
| dc.date.available | 2021-02-22T11:37:08Z | |
| dc.date.issued | 2021-01 | |
| dc.identifier.citation | McGrane J et al. The Impact of Treatment Crossover and Prostate-specific Antigen Flare with Enzalutamide and Abiraterone in Metastatic Castrate Resistant Prostate Cancer. Clin Oncol (R Coll Radiol). 2021 Jan;33(1):e92. doi: 10.1016/j.clon.2020.07.009. Epub 2020 Jul 29. | en_US |
| dc.identifier.pmid | 32739115 | |
| dc.identifier.doi | 10.1016/j.clon.2020.07.009 | |
| dc.identifier.uri | https://rde.dspace-express.com/handle/11287/621623 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Science | en_US |
| dc.relation.url | https://linkinghub.elsevier.com/retrieve/pii/S0936-6555(20)30291-0 | en_US |
| dc.rights | © 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. | en_US |
| dc.subject | Prostate Cancer | en_US |
| dc.subject | Treatment Crossover | en_US |
| dc.subject | Antigen Flare | en_US |
| dc.subject | Enzalutamide | en_US |
| dc.subject | Abiraterone | en_US |
| dc.subject | Wessex Classification Subject Headings::Oncology. Pathology. | en_US |
| dc.title | The Impact of Treatment Crossover and Prostate-specific Antigen Flare with Enzalutamide and Abiraterone in Metastatic Castrate Resistant Prostate Cancer | en_US |
| dc.type | Letter | en_US |
| dc.identifier.journal | Clinical Oncology | en_US |
| dc.type.version | Published | en_US |
| dc.description.admin-note | published version, accepted version (12 month embargo) | en_US |
